Preview

Current Pediatrics

Advanced search

Wells Syndrome in Children: Case Study and Differential Diagnostics

https://doi.org/10.15690/vsp.v19i6.2156

Abstract

Background. Wells syndrome (eosinophilic cellulitis) is recurrent granulomatous dermatitis with peripheral blood eosinophilia. This is extremely rare pathology, therefore, there are no reliable epidemiological data on its prevalence. Only about 200 cases were recorded worldwide and 30 of them among children according to the meta-analysis (2012). The disease is mostly sporadic, there are rare family cases, according to the results of little number of scientific publications.

Clinical Case Description. The clinical case of Wells syndrome in female 4 years old patient is presented. Clinical findings included symmetrical skin lesions, nodes and large irregular edematous plaques of red-purple color with clear fluid vesicles on its surface. The disease had wavy course: rashes have recovered spontaneously over 7–10 days, new elements appeared alongside with feeling unwell, fever up to 37,8°C and abdominal pain. Similar clinical findings of rashes were observed in paternal relatives of the child.

Conclusion. Differential diagnostics of Wells syndrome should be carried out with skin granulomatous diseases and hypereosinophilic syndrome that may be characterized by similar clinical findings. Verification of Wells syndrome diagnosis is complicated due to its rareness, low awareness of dermatologists and pediatricians about this pathology, as well as ignoring the need to carry out histological tests during the disease exacerbation.

About the Authors

Nikolay N. Murashkin
National Medical Research Center of Children’s Health; Research Institute of Pediatrics and Children’s Health in “Central Clinical Hospital of the Russian Academy of Sciences”; Sechenov First Moscow State Medical University (Sechenov University); Central State Medical Academy of Department of Presidential Affairs
Russian Federation

Moscow


Disclosure of interest:

Nikolay N. Murashkin — receiving research grants from pharmaceutical companies Jansen, Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma PLC. Scientific consultant of Galderma, Pierre Fabre, Bayer, LEO Pharma, Pfizer, AbbVie



Eduard T. Ambarchian
National Medical Research Center of Children’s Health; Research Institute of Pediatrics and Children’s Health in “Central Clinical Hospital of the Russian Academy of Sciences”
Russian Federation
Moscow
Disclosure of interest:

Eduard T. Ambarchian — receiving research grants from pharmaceutical companies Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma PLC. Scientific consultant of Johnson & Johnson company



Roman V. Epishev
National Medical Research Center of Children’s Health; Research Institute of Pediatrics and Children’s Health in “Central Clinical Hospital of the Russian Academy of Sciences”
Russian Federation
Moscow
Disclosure of interest:

Alexander I. Materikin, Roman V. Epishev — receiving research grants from pharmaceutical companies Eli Lilly, Novartis



Alexander I. Materikin
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Disclosure of interest:

Alexander I. Materikin, Roman V. Epishev — receiving research grants from pharmaceutical companies Eli Lilly, Novartis



Leonid A. Opryatin
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Disclosure of interest:

The other contributors confirmed the absence of a reportable conflict of interests



Roman A. Ivanov
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Disclosure of interest:

The other contributors confirmed the absence of a reportable conflict of interests



Daria S. Kukoleva
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Disclosure of interest:

The other contributors confirmed the absence of a reportable conflict of interests



References

1. Sinno H, Lacroix J.-P, Lee J, et al. Diagnosis and management of eosinophilic cellulitis (Wells’ syndrome): A case series and literature review. Can J Plast Surg. 2012;20(2):91–97. doi: 10.1177/229255031202000204.

2. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc. 1971;57(1):46–56.

3. Wells GC, Smith NP. Eosinophilic cellulitis. Br J Dermatol. 1979; 100(1):101–109. doi: 10.1111/j.1365-2133.1979.tb03574.x.

4. Weins AB, Biedermann T, Weiss T, Weiss JM. Wells syndrome. J Dtsch Dermatol Ges. 2016;14(10):989–993. doi: 10.1111/ddg.13132.

5. Rajpara A, Liolios A, Fraga G, Blackmon J. Recurrent paraneoplastic Wells syndrome in a patient with metastatic renal cell cancer. Dermatol Online J. 2014; 20(6): 13030/qt35w8r1g3.

6. Murat O., Ucan E., Ibiloglu I. Eosinophilic Cellulitis Successfully Treated with Colchicine. Indian Dermatol Online J. 2019;10(4): 467–468. doi: 10.4103/idoj.IDOJ_387_18.

7. Yu AM, Ito S, Leibson T, et al. Pediatric Wells syndrome (eosinophilic cellulitis) after vaccination: A case report and review of the literature. Pediatr Dermatol. 2018;35(5):e262–e264. doi: 10.1111/pde.13532.

8. Heelan K, Ryan JF, Shear NH, Egan CA. Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep. 2013;7(4): 113–120. doi: 10.3315/jdcr.2013.1157.

9. Silva CMR, Ottoni FA, Andrade-Filho JS, et al. Do you know this syndrome? An Bras Dermatol. 2007;82:575–578.

10. Brasileiro LG, de Abreu MAMM, Paschoal RS. Wells’ syndrome: the importance of differential diagnosis. An Bras Dermatol. 2019; 94(3):370–372. doi: 10.1590/abd1806-4841.20197840.

11. Aberer W, Konrad K, Wolff K. Wells’ syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Derm. 1988;18(1 Pt 1):105–114. doi: 10.1016/s0190-9622(88)70016-x.

12. Caputo R, Marzano AV, Vezzoli P, Lunardon L. Wells syndrome in adults and children: A report of 19 cases. Arch Dermatol. 2006; 142(9):1157–1161. doi: 10.1001/archderm.142.9.1157.

13. Ghosh S, Bhattacharya M, Dhar S. Churg-Strauss syndrome. Indian J Dermatol. 2011;56(6):718–721. doi: 10.4103/0019-5154.91836.

14. Herchline TE, Swaminathan S, Chandrasekar PH, Bronze MS. Cellulitis. Upd.: Jun 14, 2019. Available online: https://emedicine.medscape.com/article/214222. Accessed on 10 October, 2020.

15. Mitchell AJ, Anderson TF, Headington JT, Rasmussen JE. Recurrent granulomatous dermatitis with eosinophilia. Wells’ syndrome. Int J Dermatol. 1984;23(3):198–202. doi: 10.1111/j.1365-4362.1984.tb04511.x.

16. Bogenrieder T, Griese DP, Schiffner R, et al. Wells’ syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol. 1997;137(6):978–982.

17. Qiao J, Sun CE, Zhu W, et al. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease? Int J Exp Pathol. 2013;6(8): 1683–1687.

18. Powell J, Kaur M, Muc R, et al. Persistent hypereosinophilia with Wells syndrome. Clin Exp Dermatol. 2012;38(1):40–43. doi: 10.1111/j.1365-2230.2012.04370.x.

19. Verma P, Singal A, Sharma S. Idiopathic bullous eosinophilic cellulitis (Wells syndrome) responsive to topical tacrolimus and antihistamine combination. Indian J Dermatol Venereol Leprol. 2012;78:378–380.

20. Gilliam AE, Bruckner AL, Howard RM, et al. Bullous “cellulitis” with eosinophilia: case report and review of Wells’ syndrome in childhood. Pediatrics. 2005;116(1):e149–e155. doi: 10.1542/peds.2004-2273.

21. Iglesias Puzas A, Mesa Alvarez L, Florez Menendez A, et al. Wells’ Syndrome Successfully Treated with Colchicine. Case Rep Dermatol. 2017;9(2):65–69. doi: 10.1159/000477756.

22. Herout S, Bauer WM, Schuster C, Stingl G. Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab. JAAD Case Rep. 2018;4(6):548–550. doi: 10.1016/j.jdcr.2018.02.011.


Review

For citations:


Murashkin N.N., Ambarchian E.T., Epishev R.V., Materikin A.I., Opryatin L.A., Ivanov R.A., Kukoleva D.S. Wells Syndrome in Children: Case Study and Differential Diagnostics. Current Pediatrics. 2020;19(6):490-495. (In Russ.) https://doi.org/10.15690/vsp.v19i6.2156

Views: 1767


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)